Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

September 16, 2024

Study Completion Date

November 10, 2024

Conditions

Post-Traumatic Stress DisordersMajor Depressive Disorder

Interventions

DRUG

Ketamine

Six infusions of intravenous 0.5 mg/kg ketamine hydrochloride solution over 3 weeks.

OTHER

Normal Saline

Six infusions of intravenous normal saline solution over 3 weeks.

Trial Locations (1)

Minneapolis Veterans Affairs Health Care System, Minneapolis

All Listed Sponsors

collaborator

Minneapolis Veterans Affairs Medical Center

FED

lead

University of Minnesota

OTHER

NCT04032301 - Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans | Biotech Hunter | Biotech Hunter